Post-operative recurrence in Crohn's disease: Critical analysis of potential risk factors. An update

Surgeon

Volumn 13, Issue 6, 2015, Pages 330-347

  Fornaro, Rosario ^a   Caratto, Elisa ^a   Caratto, Michela ^a   Fornaro, Francesco ^a   Caristo, Giuseppe ^a   Frascio, Marco ^a   Sticchi, Camilla ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b Agenzia Regionale Sanitaria Liguria   (Italy)

Author keywords

Crohn's disease; Postoperative recurrence; Postoperative treatment; Surgery; Surveillance

Indexed keywords

ABDOMINAL SURGERY; CROHN DISEASE; HEALTH; HUMAN; INCIDENCE; POSTOPERATIVE PERIOD; RECURRENT DISEASE; RISK FACTOR;

CROHN DISEASE; DIGESTIVE SYSTEM SURGICAL PROCEDURES; GLOBAL HEALTH; HUMANS; INCIDENCE; POSTOPERATIVE PERIOD; RECURRENCE; RISK FACTORS;

EID: 84947615118     PISSN: 1479666X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surge.2015.04.002     Document Type: Review

References (147)

1. Poggioli G., Pierangeli F., Laureti S., Ugolini F. Review article: indication and type of surgery in Crohn's disease. Aliment Pharmacol Ther 2002, 16:59-64.
2. McLeod R.S. Surgery for inflammatory bowel diseases. Dig Dis 2003, 21(2):168-179.
3. Yamamoto T. Factors affecting recurrence after surgery for Crohn's disease. World J Gastroenterol 2005, 11(26):3971-3979.
4. Caprilli R., Gassull M.A., Escher J.C., Moser G., Munkholm P., Forbes A., et al. European evidence based consensus on the diagnosis and management of Crohn's disease: special situations. Gut 2003, 55(Suppl.1):i36-58.
5. Kamm M.A., Ng S.C. Perianal fistulizing Crohn's disease: a call to action. Clin Gastroenterol Hepatol 2008 Jan, 6(1):7-10.
6. Lee E.C., Papaioannou N. Minimal surgery for chronic obstruction in patients with extensive or universal Crohn's disease. Ann R Coll Surg Engl 1982, 64(4):229-233.
7. Fazio V.W., Tjandra J.J. Strictureplasty for Crohn's disease with multiple long strictures. Dis Colon Rectum 1993, 36(1):71-72.
8. Fazio V.W., Aufses A.H. Evolution of surgery for Crohn's disease: a century of progress. Dis Colon Rectum 1999, 42(8):979-988.
9. Poggioli G., Laureti S., Pierangeli F., Ugolini F. A new model of strictureplasty for multiple and long stenoses in Crohn's ileitis: side-to-side diseased to disease-free anastomosis. Dis Colon Rectum 2003, 46(1):127-130.
10. Hanauer S.B., Korelitz B.I., Rutgeerts P., Peppercorn M.A., Thisted R.A., Cohen R.D., et al. Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial. Gastroenterology 2004, 127(3):723-729.
11. Michelassi F., Upadhyay G.A. Side-to-side isoperistaltic strictureplasty in the treatment of extensive Crohn's disease. J Surg Res 2004 Mar, 117(1):71-78.
12. Tonelli F., Fedi M., Paroli G.M., Fazi M. Indications and results of side-to-side isoperistaltic strictureplasty in Crohn's disease. Dis Colon Rectum 2004, 47(4):494-501.
13. Simillis C., Purkayastha S., Yamamoto T., Strong S.A., Darzi A.W., Tekkis P.P. A meta-analysis comparing conventional end-to-end anastomosis vs. other anastomotic configurations after resection in Crohn's disease. Dis Colon Rectum. 2007, 50(10):1674-1687.
14. Rutgeerts P., Geboes K., Vantrappen G., Beyls J., Kerremans R., Hiele M.G. Predictability of the postoperative course of Crohn's disease. Gastroenterology 1990, 99(4):956-963.
15. Froehlich F., Juillerat P., Pittet V., Felley C., Mottet C., Vader J.P., et al. Maintenance of surgically induced remission of Crohn's disease. Digestion 2007, 76(2):130-135.
16. Sorrentino D., Terrosu G., Avellini C., Maiero S. Infliximab with low-dose methotrexate for prevention of postsurgical recurrence of ileocolonic Crohn disease. Arch Intern Med 2007, 167(16):1804-1807.
17. Khoury W., Strong S.A., Fazio V.W., Kiran R.P. Factors associated with operative recurrence early after resection for Crohn's disease. J Gastrointest Surg 2011, 15(18):1354-1360.
18. Eugene C. The second European evidence-based consensus on the diagnosis and management of Crohn's disease. Clin Res Hepatol Gastroenterol 2011, 35(4):257-259.
19. Van Assche G., Dignass A., Panes J., Beaugerie L., Karagiannis J., Allez M., et al. The second European evidence-based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. J Crohns Colitis 2010, 4(1):7-27.
20. Tytgat G.N., Mulder C.J., Brummelkamamp W.H. Endoscopic lesions in Crohn's disease early after ileocecal resection. Endoscopy 1988, 20(5):260-262.
21. Michelassi F., Balestracci T., Chappell R., Block G.E. Primary and recurrent Crohn's disease. Experience with 1379 patients. Ann Surg 1991, 214(3):230-238.
22. Caprilli R., Corrao G., Taddei G., Tonelli F., Torchio P., Viscido A. Gruppo Italiano per lo Studio del Colon e del Retto (GISC). Prognostic factors for postoperative recurrence of Crohn's disease. Dis Colon Rectum 1996, 39(3):335-341.
23. Rutgeerts P. Strategies in the prevention of post-operative recurrence in Crohn's disease. Best Pract Res Clin Gastroenterol 2003, 17(1):63-73.
24. Froehlich F., Juillerat P., Felley C., Mottet C., Vader J.P., Burnand B., et al. Treatment of postoperative Crohn's disease. Digestion 2005, 71(1):49-53.
25. Terdiman J.P. Prevention of postoperative recurrence in Crohn's disease. Clin Gastroenterol Hepatol 2008, 6(6):616-620.
26. Cunningham M.F., Docherty N.G., Coffey J.C., Burke J.P., O'Connel P.R. Postsurgical recurrence of ileal Crohn's disease: an update on risk factors and intervention points to a central role for impaired host-microflora homeostasis. World J Surg 2010, 34(7):1615-1626.
27. Hashash J.G., Regueiro M.D. The evolving management of postoperative Crohn's disease. Expert Rev Gastroenterol Hepatol 2012, 6(5):637-648.
28. Greenstein A.J., Lachman P., Sachar D.B., Springhorn J., Heimann T., Janowitz H.D., et al. Perforating and non-perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms. Gut 1988, 29(5):588-592.
29. Gasche C., Scholmerich J., Brynskov J., D'Haens G., Hanauer S.B., Irvine E.J., et al. A simple classification of Crohn's disease: report of the working party for the world congresses of gastroenterology, Vienna 1998. Inflamm Bowel Dis 2000, 6(1):8-15.
30. Dubinsky M.C., Fleshner P.P. Treatment of Crohn's disease of inflammatory, stenotic, and fistulizing phenotypes. Curr Treat Options Gastroenterol 2003, 6(3):183-200.
31. Scarpa M., Angriman I., Barollo M., Polese L., Ruffolo C., Bertin M., et al. Risk factors for recurrence of stenosis in Crohn's disease. Acta Biomed 2003, 74(Suppl. 2):80-83.
32. Louis E., Van Kemseke C., Reenaers C. Necessity of phenotypic classification of inflammatory bowel disease. Best Pract Res Clin Gastroenterol 2011, 25(Suppl. 1):S2-S7.
33. Chardavoyne R., Flint G.W., Pollack S., Wise L. Factors affecting recurrence following resection for Crohn's disease. Dis Colon Rectum 1986, 29(8):495-502.
34. Poggioli G., Laureti S., Selleri S., Brignola C., Grazi G.L., Stocchi L., et al. Factors affecting recurrence in Crohn's disease. Results of a prospective audit. Int J Colorectal Dis 1996, 11:294-298.
35. Bernell O., Lapidus A., Hellers G. Risk factors for surgery and postoperative recurrence in Crohn's disease. Ann Surg 2000, 231(1):38-45.
36. Swoger J.M., Regueiro M. Preventive therapy in postoperative Crohn's disease. Curr Opin Gastroenterol 2010, 26(4):337-343.
37. Lindberg E., Järnerot G., Huitfeldt B. Smoking in Crohn's disease: effect on location and clinical course. Gut 1992, 33(6):779-782.
38. Cosnes J., Nion-Larmurier I., Afchain P., Beaugerie L., Gendre J.P. Gender differences in the response of colitis to smoking. Clin Gastroenterol Hepatol 2004, 2(1):41-48.
39. Sutherland L.R., Ramcharan S., Bryant H., Fick G. Effects of cigarette smoking on recurrence of Crohn's disease. Gastroenterology 1990, 98(5 Pt 1):1123-1128.
40. Breuer-Katschinski B.D., Hollander N., Goebell H. Effect of cigarette smoking on the course of Crohn's disease. Eur J Gastroenterol Hepatol 1996, 8(3):225-228.
41. Yamamoto T., Keighley M.R. The association of cigarette smoking with a high risk of recurrence after ileocolonic resection for ileocecal Crohn's disease. Surg Today 1999, 29(6):579-580.
42. Ryan W.R., Allan R.N., Yamamoto T., Keighley M.R. Crohn's disease patients who quit smoking have a reduced risk of reoperation for recurrence. Am J Surg 2004, 187(2):219-225.
43. Nos P., Domenech E. Postoperative Crohn's disease recurrence: a pratical approach. World J Gastroenterol 2008, 14(36):5540-5548.
44. Seoane Vigo M., Grobas P.J., Berdeal Diaz M., Freire M.C., Alejandro A.B., Dovigo A.G., et al. Factors affecting the postoperative recurrence of Crohn's disease. New controversies with one centre's experience [article in Spanish]. Cir Esp 2011, 89(5):290-299.
45. Swoger J.M., Regueiro M. Postoperative Crohn's disease. How can we prevent it?. Expert Rev Clin Immunol 2010, 6(4):501-504.
46. Papay P., Reinisch W., Ho E., Gratzer C., Lissner D., Herkner H., et al. The impact of thiopurines on the risk of surgical recurrence in patients with Crohn's disease after first intestinal surgery. Am J Gastroenterol 2010, 105(5):1158-1164.
47. Cottone M., Orlando A., Viscido A., Calabrese E., Camma C., Casa A. Review article: prevention of postsurgical relapse and recurrence in Crohn's disease. Aliment Pharmacol Ther 2003, 17(Suppl. 2):38-42.
48. Yamamoto T., Keighley M.R. Smoking and disease recurrence after operation for Crohn's disease. Br J Surg 2000, 87(4):398-404.
49. Yamamoto T., Allan R.N., Keighley M.R. Smoking is a predictive factor for outcome after colectomy and ileorectal anastomosis in patients with Crohn's colitis. Br J Surg 1999, 86:1069-1070.
50. Hofer B., Bottger T., Hernandez-Richter T., Seifert J.K., Junginger T. The impact of clinical types of disease manifestation on the risk of early postoperative recurrence in Crohn's disease. Hepatogastroenterology 2001, 48(37):152-155.
51. Renna S., Orlando A., Orlando R., Cottone M. Problems related to postoperative clinical relapse an endoscopic recurrence in Crohn's disease. Recenti Prog Med 2009, 100(10):469-478. [article in Italian].
52. Aeberhard P., Berchtold W., Riedtmann H.J., Stadelmann G. Surgical recurrence of perforating and nonperforating Crohn's disease: a study of 101 surgically treated patients. Dis Colon Rectum 1996, 39(1):80-87.
53. Simillis Yamamoto T., Reese G.E., Umegae S., Matsumoto K., Darzi A.W., et al. A meta-analysis comparing incidence of recurrence and indication for reoperation after surgery for perforating versus nonperforating Crohn's disease. Am J Gastroenterol 2008, 103(1):196-205.
54. Yamamoto T., Allan R.N., Keighley M.R. Perforating ileocecal Crohn's disease does not carry a high risk of recurrence but usually re-presents as perforating disease. Dis Colon Rectum 1999, 42(4):519-524.
55. Whelan G., Farmer R.G., Fazio V.W., Goormastic M. Recurrence after surgery in Crohn's disease. Relationship to location of disease (clinical pattern) and surgical indication. Gastroenterology 1985, 88(6):1826-1833.
56. Wolff B.G. Factors determining recurrence following surgery for Crohn's disease. World J Surg 1998, 22(4):364-369.
57. Klaus J., Spaniol U., Adler G., Mason R.A., Reinshagen M., von Tirpitz C. Small intestinal bacterial overgrowth mimicking acute flare as a pitfall in patients with Crohn's Disease. BMC Gastroenterol 2009, 9:61. 10.1186/1471-230X-9-61.
58. Rana S.V., Sharma S., Malik A., Kaur J., Prasad K.K., Sinha S.K., et al. Small intestinal bacterial overgrowth and orocecal transit time in patients of inflammatory bowel disease. Dig Dis Sci 2013, 58:2594-2598.
59. Castiglione F., Del Vecchio Blanco G., Rispo A., Petrelli G., Amalfi G., Cozzolino A., et al. Orocecal transit time and bacterial overgrowth in patients with Crohn's disease. J Clin Gastroenterol 2000, 31:63-66.
60. Ambe R., Campbell L., Cagir B. A comprehensive review of strictureplasty techniques in Crohn's disease: types, indications, comparisons, and safety. J Gastrointest Surg 2012, 16(1):209-217.
61. Fornaro R., Secco G.B., Picori E., Stabilini C., Frascio M., Ricci B., et al. La terapia chirurgica nelle complicanze della malattia di Crohn. Nostra esperienza. G Chir 2006, 27(1-2):21-26. [article in Italian].
62. Anseline P.F., Wlodarczyk J., Murugasu R. Presence of granulomas is associated with recurrence after surgery for Crohn's disease: experience of a surgical unit. Br J Surg 1997, 84(1):78-82.
63. Chambers T.J., Morson B.C. The granuloma in Crohn's disease. Gut 1979, 20(4):269-274.
64. Wolff B.G., Beart R.W., Frydenberg H.B., Weiland L.H., Agrez M.V., Ilstrup D.M. The importance of disease-free margins in resections for Crohn's disease. Dis Colon Rectum 1983, 26(4):239-243.
65. Fazio V.W., Marchetti F., Church M., Goldblum J.R., Lavery C., Hull T.L., et al. Effect of resection margins on the recurrence of Crohn's disease in the small bowel: a randomized controlled trial. Ann Surg 1996, 224(4):563-571. discussion 571-3.
66. Dietz D.W., Laureti S., Strong S.A., Hull T.L., Church J., Remzi F.H., et al. Safety and long term efficacy of strictureplasty in 314 patients with obstructing small bowel Crohn's disease. J Am Coll Surg 2001, 192(3):330-337. discussion 337-8.
67. Yamamoto T., Bain I.M., Mylonakis E., Allan R.N., Keighley M.R. Stapled functional end-to-end anastomosis versus sutured end-to-end anastomosis after ileocolonic resection in Crohn disease. Scand J Gastroenterol 1999, 34(7):708-713.
68. Tersigni R., Alessandroni L., Barreca M., Piovanello P., Prantera C. Does stapled functional end-to-end anastomosis affect recurrence of Crohn's disease after ileocolonic resection?. Hepatogastroenterology 2003 , 50(53):1422-1425.
69. Scarpa M., Angriman I., Barollo M., Polese L., Ruffolo C., Bertin M., et al. Role of stapled and hand-sewn anastomoses in recurrence of Crohn's disease. Hepatogastroenterology 2004 , 51(58):1053-1057.
70. Sayfan J., Wilson D.A., Allan A., Andrews H., Alexander-Williams J. Recurrence after strictureplasty or resection for Crohn's disease. Br J Surg 1989, 76(4):335-338.
71. Rosman A.S., Melis M., Fichera A. Metaanalysis of trials comparing laparoscopic and open surgery for Crohn's disease. Surg Endosc 2005, 19(12):1549-1555.
72. Lowney J.K., Dietz D.W., Birnbaum E.H., Kodner I.J., Mutch M.G., Fleshman J.W. Is there any difference in recurrence rates in laparoscopic ileocolic resection for Crohn's disease compared with conventional surgery? A long-term, follow-up study. Dis Colon Rectum 2006 , 49(1):58-63.
73. Riss S., Bittermann C., Schwameis K., Kristo I., Mittlböck M., Herbst F., et al. Determinants for postoperative complications after laparoscopic intestinal resection for Chron's disease. Surg Endosc 2012, 26(4):933-938.
74. Holzheimer R.G., Molloy R.G., Wittmann D.H. Postoperative complications predict recurrence of Crohn's disease. Eur J Surg 1995 , 161(2):129-135.
75. Williams J.G., Hughes L.E. Effect of perioperative blood transfusion on recurrence of Crohn's disease. Lancet 1989, 2(8655):131-133.
76. Peters W.R., Fry R.D., Fleshman J.W., Kodner I.J. Multiple blood transfusions reduce the recurrence rate of Crohn's disease. Dis Colon Rectum 1989, 32(9):749-753.
77. Gooszen H.G., Silvis R. Protective effect of blood transfusions on postoperative recurrence of Crohn's disease in parous women. Neth J Med 1994, 45(2):65-71.
78. Hollaar G.L., Gooszen H.G., Post S., Williams J.G., Sutherland L.R. Perioperative blood transfusion does not prevent recurrence in Crohn's disease. A pooled analysis. J Clin Gastroenterol 1995, 21(2):134-138.
79. Sokol H., Polin V., Lavergne-Slove A., Panis Y., Treton X., Dray X., et al. Plexitis as a predictive factor of early postoperative clinical recurrence in Crohn's disease. Gut 2009, 58(9):1218-1225. 10.1136/gut.2009.177782.
80. Ferrante M., de Hertogh G., Hlavaty T., D'Haens G., Penninckx F., D'Hoore A., et al. The value of myenteric plexitis to predict early postoperative Crohn's disease recurrence. Gastroenterology 2006, 130:1595-1606.
81. Bressenot A., Chevaux J.B., Williet N., Oussalah A., Germain A., Gauchotte G., et al. Submucosal plexitis as a predictor of postoperative surgical recurrence in Crohn's disease. Inflamm Bowel Dis 2013, 19(8):1654-1661.
82. Culligan K., Coffey J.C., Kiran R.P., Kalady M., Lavery I.C., Remzi F.H. The mesocolon: a prospective observational study. Colorectal Dis 2012, 14(4):421-428. discussion 428-30.
83. Culligan K., Sehgal R., Mulligan D., Dunne C., Walsh S., Quondamatteo F., et al. A detailed appraisal of mesocolic lymphangiology-an immunohistochemical and stereological analysis. J Anat 2014, 225(4):463-472.
84. Culligan K., Walsh S., Dunne C., Walsh M., Ryan S., Quondamatteo F., et al. The mesocolon: a histological and electron microscopic characterization of the mesenteric attachment of the colon prior to and after surgical mobilization. Ann Surg 2014, 260(6):1048-1056. 10.1097/SLA.0000000000000323.
85. Zulian A., Cancello R., Micheletto G., Gentilini D., Gilardini L., Danelli P., et al. Visceral adipocytes: old actors in obesity and new protagonists in Crohn's disease?. Gut 2012, 61(1):86-94. [Epub 2011 Sep 19]. 10.1136/gutjnl-2011-300391.
86. Drouet M., Dubuquoy L., Desreumaux P., Bertin B. Visceral fat and gut inflammation. Nutrition 2012, 28(2):113-117. 10.1016/j.nut.2011.09.009.
87. Crohn B.B., Ginzburg L., Oppenheimer G.D. Landmark article Oct 15, 1932. Regional ileitis. A pathological and clinical entity. By Burril B. Crohn, Leon Ginzburg, and Gordon d. Oppenheimer. JAMA 1984, 251:73-79.
88. Peyrin Biroulet L., Chamaillard M., Gonzalez F., Beclin E., Decourcelle C., Antunes L., et al. Mesenteric fat in Crohn's disease: a pathogenetic hallmark or an innocent by stander?. Gut 2007, 56(4):577-583. 10.1136/gut.2005.082925.
89. Fink C., Karagiannides I., Bakirtzi K., Pothoulakis C. Adipose tissue and inflammatory bowel disease pathogenesis. Inflamm Bowel Dis 2012, 18(8):1550-1557. 10.1002/ibd.22893.
90. Paul G., Schaffler A., Neumeier M., Furst A., Bataillle F., Buechler C., et al. Profiling adipocytokine secretion from creeping fat in Crohn's disease. Inflamm Bowel Dis 2006, 12(6):471-477. 10.1097/00054725-200606000-00005.
91. Kredel L.I., Siegmund B. Adipose-tissue and intestinal inflammation - visceral obesity and creeping fat. Front Immunol 2014 Sep, 24(5):462. eCollection 2014. 10.3389/fimmu.2014.00462.
92. Peyrin-Biroulet L., Gonzalez F., Dubuquoy L., Rousseaux C., Dubuquoy C., Decourcelle C., et al. Mesenteric fat as a source of C reactive protein and as a target for bacterial translocation in Crohn's disease. Gut 2012, 61(1):78-85.
93. Li Y., Zhu W., Gong J., Zhang W., Gu L., Guo Z., et al. Visceral fat area is associated with a high risk for early postoperative recurrence in Crohn's disease. Colorectal Dis 2015 Mar, 17(3):225-234. 10.1111/codi.12798.
94. Caprilli R., Andreoli A., Capurso L., Corrao G., D'Albasio G., Gioieni A., et al. Oral mesalazine (5- aminosalicylic acid; Asacol) for the prevention of postoperative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC). Aliment Pharmacol Ther 1994 Feb, 8(1):35-43.
95. Brignola C., Cottone M., Pera A., Ardizzone S., Scribano M.L., De Franchis R., et al. Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's disease. Italian cooperative study group. Gastroenterology 1995 Feb, 108(2):345-349.
96. McLeod R.S., Wolff B.G., Steinhart A.H., Carryer P.W., O'Rourke K., Andrews D.F., et al. Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn's disease. Gastroenterology 1995 Aug, 109(2):404-413.
97. Schwartz M., Regueiro M. Prevention and treatment of postoperative Crohn's disease recurrence: an update for a new decade. Curr Gastroenterol Rep 2011 Feb, 13(1):95-100.
98. Lemann M. Review article: can post-operative recurrence in Crohn's disease be prevented?. Aliment Pharmacol Ther 2006 Oct, 24(Suppl. 3):22-28.
99. Doherty G., Bennett G., Patil S., Cheifetz A., Moss A.C. Interventions for prevention of post-operative recurrence of Crohn's disease. Cochrane Database Syst Rev 2009 Oct 7, (4):CD006873.
100. Ford A.C., Kane S.V., Khan K.J., Achkar J.P., Talley N.J., Marshall J.K., et al. Efficacy of 5- aminosalicylates in Crohn's disease: systematic review and meta-analysis. Am J Gastroenterol 2011, 106(4):617-629.
101. Ardizzone S., Maconi G., Sampietro G.M., Russo A., Radice E., Colombo E., et al. Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease. Gastroenterology 2004 Sep, 127(3):730-740.
102. Reinisch W., Angelberger S., Petritsch W., Shonova O., Lukas M., Bar-Meir S., et al. Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial. Gut 2010, 59:752-759.
103. Doherty G.A., Miksad R.A., Cheifetz A.S., Moss A.C. Comparative cost-effectiveness of strategies to prevent postoperative clinical recurrence of Crohn's disease. Inflamm Bowel Dis 2012 Sep, 18(9):1608-1616.
104. Subramanian V., Pollok R.C., Kang J.Y., Kumar D. Systematic review of postoperative complications in patients with inflammatory bowel disease treated with immunomodulators. Br J Surg 2006 Jul, 93(7):793-799.
105. Mowat C., Cole A., Windsor A., Ahmad T., Arnott I., Driscoll R., et al. Guidelines for the management of inflammatory bowel disease in adults. Gut 2011 May, 60(5):571-607.
106. Myrelid P., Olaison G., Sjodahl R., Nyström P.O., Almer S., Andersson P. Thiopurine therapy is associated with postoperative intra-abdominal septic complications in abdominal surgery for Crohn's disease. Dis Colon Rectum 2009 Aug, 52(8):1387-1394.
107. Cho S.M., Cho S.W., Regueiro M. Postoperative management of Crohn's disease. Gastroenterol Clin North Am 2009 Dec, 38(4):753-762.
108. Ahmed T., Rieder F., Fiocchi C., Achkar J.P. Pathogenesis of postoperative recurrence in Crohn's disease. Gut 2011 Apr, 60(4):553-562.
109. Rutgeerts P., Hiele M., Geboes K., Peeters M., Penninckx F., Aerts R., et al. Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology 1995 Jun, 108(6):1617-1621.
110. Rutgeerts P., Van Assche G., Vermeire S., D'Haens G., Baert F., Noman M., et al. Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trial. Gastroenterology 2005, 128:856-861.
111. Rutgeerts P., Feagan B.G., Lichtenstein G.R., Mayer L.F., Schreiber S., Colombel J.F., et al. Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease. Gastroenterology 2004 Feb, 126(2):402-413.
112. Prantera C., Zannoni F., Scribano ML,Berto E., Andreoli A., Kohn A., et al. An antibiotic regimen for the treatment of active Crohn's disease: a randomized, controlled clinical trial of metronidazole plus ciprofloxacin. Am J Gastroenterol 1996 Feb, 91(2):328-332.
113. Colombel J.F., Lemann M., Cassagnou M., Bouhnik Y., Duclos B., Dupas J.L., et al. A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn's disease. Am J Gastroenterol 1999 Mar, 94(3):674-678.
114. Shen B., Achkar J.P., Lashner B.A., Ormsby A.H., Remzi F.H., Brzezinski A., et al. A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis. Inflamm Bowel Dis 2001 Nov, 7(4):301-305.
115. Thia K.T., Mahadevan U., Feagan B.G., Wong C., Cockeram A., Bitton A., et al. Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with CD: a randomized, double-blind, placebo controlled pilot study. Inflamm Bowel Dis 2009 Jan, 15(1):17-24.
116. Benchimol E.I., Seow C.H., Otley A.R., Steinhart A.H. Budesonide for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev 2009 Jan 21, (1):CD002913.
117. Gionchetti P., Calabrese C., Tambasco R., Brugnera R., Straforini G., Liguori G., et al. Role of conventional therapies in the era of biological treatment in Crohn's disease. World J Gastroenterol 2011 Apr 14, 17(14):1797-1806.
118. Rolfe V.E., Fortun P.J., Hawkey C.J., Bath-Hextall F. Probiotics for maintenance of remission in CD. Cochrane Database Syst Rev 2006 Oct 18, (4):CD004826.
119. Bourreille A., Cadiot G., Le Dreau G., Laharie D., Beaugerie L., Dupas J.L., et al. Saccharomyces boulardii does not prevent relapse of Crohn's disease. Saccharomyces boulardii does not prevent relapse of Crohn's disease. Clin Gastroenterol Hepatol 2013 Aug, 11(8):982-987.
120. Schultz M., Timmer A., Herfarth H.H., Sartor R.B., Vanderhoof J.A., Rath H.C. Lactobacillus GG in inducing and maintaining remission of Crohn's disease. BMC Gastroenterol 2004 Mar, 15(4):5.
121. Colombo E., Bossa F., Latiano A., Palmieri O., Andriulli A., Annese V. New biologics in the management of Crohn's disease: focus on certolizumab pegol. Clin Exp Gastroenterol 2009, 2:61-68.
122. Hanauer S.B., Feagan B.G., Lichtenstein G.R., Mayer L.F., Schreiber S., Colombel J.F., et al. Maintenance infliximab for Crohn's disease: the ACCENT I randomized trial. Lancet 2002, 359:1541-1549.
123. Colombel J.F., Ricart E., Loftus E.V., Tremaine W.J., Young-Fadok T., Dozois E.J., et al. Management of Crohn's disease of the ileoanal pouch with infliximab. Am J Gastroenterol 2003 Oct, 98(10):2239-2244.
124. Yamamoto T. Prevention of recurrence after surgery for Crohn's disease: efficacy of infliximab. World J Gastroenterol 2010 Nov 21, 16(43):5405-5410.
125. Colombel J.F., Sandborn W.J., Reinisch W., Mantzaris G.J., Kornbluth A., Rachmilewitz D., et al. Infliximab, azathioprine, or combination therapy for Crohn's disease. N Engl J Med 2010 Apr 15, 362(15):1383-1395.
126. Colombel J.F., Sandborn W.J., Rutgeerts P., Enns R., Hanauer S.B., Panaccione R., et al. Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: CHARM trial. Gastroenterology 2007, 132:52-65.
127. Aguas M., Bastida G., Cerrillo E., Beltrán B., Iborra M., Sánchez-Montes C., et al. Adalimumab in high-risk patients. World J Gastroenterol 2012, 18:4391-4398.
128. Papamichael K., Archavlis E., Lariou C., Mantzaris G.J. Adalimumab for the prevention and/or treatment of post-operative recurrence of Crohn's disease: a prospective, two-year, single center, pilot study. J Crohns Colitis 2012, 6:924-931.
129. Sandborn W.J., Fegan B.G., Stoinov S., Honiball P.J., Rutgeerts P., Mason D., et al. Certolizumab pegol for the treatment of Crohn's disease. N Engl J Med 2007, 357:228-238.
130. Schreiber S., Khaliqkareemi M., Lawrance I.C., Thomsen O.Ø., Hanauer S.B., McColm J., et al. Maintenance therapy with certolizumab pegol for Crohn's disease. N Engl J Med 2007 Jul, 19(357):239-250.
131. Ewe K., Herfarth C., Malchow H. Surgical and internal medicine therapy study of the postoperative prevention of recurrence in Crohn's disease - completion of a partly randomized study. Verh Dtsch Ges Inn Med 1980, 86:1327-1337.
132. Koilakou S., Sailer J., Peloschek P., Ferlitsch A., Vogelsang H., Miehsler W., et al. Endoscopy and MR enteroclysis: equivalent tools in predicting clinical recurrence in patients with Crohn's disease after ileocolic resection. Inflamm Bowel Dis 2010 Feb, 16(2):198-203.
133. Cottone M., Rosselli M., Orlando A., Oliva L., Puleo A., Cappello M., et al. Smoking habits and recurrence in Crohn's disease. Gastroenterology 1994 Mar, 106(3):643-648.
134. Polle S.W., Slors J.F., Weverling G.J., Gouma D.J., Hommes D.W., Bemelman W.A. Recurrence after segmental resection for colonic Crohn's disease. Br J Surg 2005 Sep, 92(9):1143-1149.
135. Sachar D.B. Patterns of postoperative recurrence in Crohn's disease. Scand J Gastroenterol Suppl 1990, 172:35-38.
136. Spinelli A., Sacchi M., Fiorino G., Danese S., Montorsi M. Risk of postoperative recurrence and postoperative management of Crohn's disease. World J Gastroenterol 2011 Jul 21, 17(27):3213-3219.
137. Ryan W.R., Ley C., Allan R.N., Keighley M.R. Patients with Crohn's disease are unaware of the risks that smoking has on their disease. J Gastrointest Surg 2003 Jul-Aug, 7(5):706-711.
138. Blum E., Katz J.A. Postoperative therapy for Crohn's disease. Inflamm Bowel Dis 2009 Mar, 15(3):463-472.
139. Dignass A., Van Assche G., Lindsay J.O., Lémann M., Söderholm J., Colombel J.F., et al. The second European evidence-based consensus on the diagnosis and management of Crohn's disease: current management. J Crohns Colitis 2010 Feb, 4(1):28-62.
140. Ananthakrishnan A.N., Hur C., Juillerat P., Korzenik J.R. Strategies for the prevention of postoperative recurrence in Crohn's disease: results of a decision analysis. Am J Gastroenterol 2011 Nov, 106(11):2009-2017.
141. Vaughn B.P., Moss A.C. Prevention of post-operative recurrence of Crohn's disease. World J Gastroenterol 2014 Feb 7, 20(5):1147-1154.
142. Roy P., Kumar D. Strictureplasty. Br J Surg 2004 Nov, 91(11):1428-1437.
143. Dietz D.W., Fazio V.W., Laureti S., Strong S.A., Hull T.L., Church J., et al. Strictureplasty in diffuse Crohn's jejunoileitis: safe and durable. Dis Colon Rectum 2002 Jun, 45(6):764-770.
144. Collier P., Turowski P., Diamond D.L. Small intestinal adenocarcinoma complicating regional enteritis. Cancer 1985 Feb 1, 55:516-521.
145. Wettergren A., Christiansen J. Risk of recurrence after resection for ileocolonic Crohn's disease. Scand J Gastroenterol 1991 Dec, 26(12):1319-1322.
146. Williams J.G., Wong W.D., Rothenberger D.A., Goldberg S.M. Recurrence of Crohn's disease after resection. Br J Surg 1991 Jan, 78(1):10-19.
147. Campbell L., Ambe R., Weaver J., Marcus S.M., Cagir B. Comparison of conventional and nonconventional strictureplasties in Crohn's disease: a systematic review and meta-analysis. Dis Colon Rectum 2012 Jun, 55(6):714-726.